H Vinazzer. Show Affiliations »
Abstract
Mesh： See more » Afibrinogenemia/chemically inducedAncrod/administration & dosageAncrod/adverse effectsAncrod/therapeutic useBatroxobin/pharmacologyBlood Coagulation/drug effectsBlood Coagulation Disorders/chemically inducedBlood Platelet Disorders/chemically inducedBlood Platelets/drug effectsDrug ResistanceEndopeptidases/therapeutic useFibrinogen/analysisFibrinolysis/drug effectsHumansInjections, IntravenousInjections, SubcutaneousPlatelet Aggregation/drug effectsThrombinThrombocytopenia/chemically inducedTyrosine
Substances： See more » TyrosineFibrinogenEndopeptidasesAncrodBatroxobinThrombin
Year: 1976 PMID： 943132 DOI： 10.1016/0049-3848(76)90267-x
Source DB: PubMed Journal: Thromb Res ISSN： 0049-3848 Impact factor: 3.944